Cited by 65
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
IgE antibodies, FcεRIα, and IgE-mediated local anaphylaxis can limit snake venom toxicity
Starkl, Philipp, Marichal, Thomas, Gaudenzio, Nicolas, Reber, Laurent Lionel, Sibilano, Riccardo, Tsai, Mindy, Galli, Stephen Joseph·2016·Journal of Allergy and Clinical Immunology
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Crossref · 10.1016/j.jaci.2015.08.005
Cites
1 of 1 references verified0 citation errors · 0 not checkable
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in mice surviving an initial encounter with venom, acquired type 2 immune responses, IgE antibodies, the high affinity IgE receptor (FcεRI), and mast cells can contribute to acquired resistance to the lethal effects of both honeybee venom and Russell’s”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [105]
In the citing paper
“However, pre-sensitization of C57BL/6 mice with anti-DNP IgG1 or IgG2b, DNP-specific IgG isotypes with the capacity to activate effector cells via Fcγ receptors [108], not only failed to increase protection but also resulted in increased hypothermia at early time points compared to vehicle-treated or IgE-sensitized mice (Fig 7, B) [105].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [105]
In the citing paper
“However, pre-sensitization of C57BL/6 mice with anti-DNP IgG1 or IgG2b, DNP-specific IgG isotypes with the capacity to activate effector cells via Fcγ receptors [108], not only failed to increase protection but also resulted in increased hypothermia at early time points compared to vehicle-treated or IgE-sensitized mice (Fig 7, B) [105].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [105]
In the citing paper
“Compared to the corresponding mast cell-sufficient mice, such naïve mast cell-deficient mice also exhibited many fewer attempts to scratch sites of RVV injection (Fig. 6, D and G).”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [105]
In the citing paper
“We found that pre-sensitization with anti-DNP IgE significantly increased the resistance of C57BL/6 (Fig 7, B and C) or BALB/c (see Fig E5, H-I in the online repository of ref. [105]) mice to challenge with a potentially lethal amount of RVV admixed with DNP-HAS [105].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [105]
In the citing paper
“Our initial findings indicate that the propensity to develop protective vs. potentially harmful type 2 immune responses to venoms, at least in mice, can depend on the genetic background of the animal, the type and amount of venom to which the animal is exposed, and/or the frequency of such venom exposures [105].”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [105]
In the citing paper
“Subsequently, we found that the acquired enhanced resistance to Russell’s viper venom (RVV) which we observed in mice that had developed type 2 immune responses to that venom [96] also was highly dependent on IgE (Fig. 5) and FcεRI (see Fig. 4, A–E in ref. [105]), and could be effectively transferred by immune serum into normal mice (see Fig. 3, F–J in ref. [105]) but not into C57BL/6-Cpa3-Cre;Mcl”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [105]
In the citing paper
“We used amounts of anti-DNP IgE and DNP-HSA that were able to induce a local increase in vascular permeability at the DNP-HSA injection site without resulting in systemic hypothermia, and showed that the amount of DNP-HSA we used did not, by itself, influence the toxicity of RVV (see Fig E5 in the Online Repository of ref. [105]).”
From Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy (2020) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE HIGH-AFFINITY I g E RECEPTOR (FcεRI): From Physiology to Pathology
Kinet, J.-P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.931 · Cited by 968
Research works printed but not linked: 91
- Berger, 1989, Snake venom components and their cross-reactivity: a review, Biochem Cell Biol, 67, 597, 10.1139/o89-092 · DOI
- Habermann, 1972, Bee and wasp venoms, Science, 177, 314, 10.1126/science.177.4046.314 · DOI · Paper page
- Fry, 2009, The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms, Annu Rev Genomics Hum Genet, 10, 483, 10.1146/annurev.genom.9.081307.164356 · DOI
- Brodie, 2009, Toxins and venoms, Curr Biol, 19, R931, 10.1016/j.cub.2009.08.011 · DOI
- Perales, 2005, Natural inhibitors of snake venom hemorrhagic metalloproteinases, Toxicon, 45, 1013, 10.1016/j.toxicon.2005.02.028 · DOI
- Voss, 2012, Snake-venom resistance as a mammalian trophic adaptation: lessons from didelphid marsupials, Biol Rev Camb Philos Soc, 87, 822, 10.1111/j.1469-185X.2012.00222.x · DOI
- Rowe, 2013, Voltage-gated sodium channel in grasshopper mice defends against bark scorpion toxin, Science, 342, 441, 10.1126/science.1236451 · DOI
- Galli, 2008, Immunomodulatory mast cells: negative, as well as positive, regulators of immunity, Nat Rev Immunol, 8, 478, 10.1038/nri2327 · DOI
- Kitamura, 1989, Heterogeneity of mast cells and phenotypic change between subpopulations, Annu Rev Immunol, 7, 59, 10.1146/annurev.iy.07.040189.000423 · DOI
- Galli, 2005, Mast cells as “tunable” effector and immunoregulatory cells: recent advances, Annu Rev Immunol, 23, 749, 10.1146/annurev.immunol.21.120601.141025 · DOI · Paper page
- Metz, 2007, Mast cells in the promotion and limitation of chronic inflammation, Immunol Rev, 217, 304, 10.1111/j.1600-065X.2007.00520.x · DOI
- Akahoshi, 2011, Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice, J Clin Invest, 121, 4180, 10.1172/JCI46139 · DOI · Paper page
- Higginbotham, 1965, Mast cells and local resistance to Russell's viper venom, J Immunol, 95, 867, 10.4049/jimmunol.95.5.867 · DOI · Paper page
- Higginbotham, 1971, The significance of the mast cell response to bee venom, J Immunol, 106, 233, 10.4049/jimmunol.106.1.233 · DOI · Paper page
- Metz, 2006, Mast cells can enhance resistance to snake and honeybee venoms, Science, 313, 526, 10.1126/science.1128877 · DOI · Paper page
- Schneider, 2007, Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin, J Exp Med, 204, 2629, 10.1084/jem.20071262 · DOI · Paper page
- Simpson, 2007, Snakes of medical importance in India: is the concept of the “Big 4” still relevant and useful?, Wilderness Environ Med, 18, 2, 10.1580/06-WEME-CO-023R1.1 · DOI
- Warrell, 1989, Snake venoms in science and clinical medicine. 1. Russell's viper: biology, venom and treatment of bites, Trans R Soc Trop Med Hyg, 83, 732, 10.1016/0035-9203(89)90311-8 · DOI
- Wernersson, 2014, Mast cell secretory granules: armed for battle, Nat Rev Immunol, 14, 478, 10.1038/nri3690 · DOI · Paper page
- Marichal, 2013, A beneficial role for immunoglobulin E in host defense against honeybee venom, Immunity, 39, 963, 10.1016/j.immuni.2013.10.005 · DOI · Paper page
- Profet, 1991, The function of allergy: immunological defense against toxins, Q Rev Biol, 66, 23, 10.1086/417049 · DOI · Paper page
- Palm, 2012, Allergic host defences, Nature, 484, 465, 10.1038/nature11047 · DOI · Paper page
- Bilo, 2005, Diagnosis of Hymenoptera venom allergy, Allergy, 60, 1339, 10.1111/j.1398-9995.2005.00963.x · DOI · Paper page
- de Medeiros, 2008, Predictors of Bothrops jararaca venom allergy in snake handlers and snake venom handlers, Toxicon, 51, 672, 10.1016/j.toxicon.2007.11.022 · DOI
- Kopp, 1993, Allergic reaction to snake venom after repeated bites of Vipera aspis, Clin Exp Allergy, 23, 231, 10.1111/j.1365-2222.1993.tb00887.x · DOI
- Reimers, 2000, Are anaphylactic reactions to snake bites immunoglobulin E-mediated?, Clin Exp Allergy, 30, 276, 10.1046/j.1365-2222.2000.00697.x · DOI
- Schmutz, 1985, Anaphylactoid reactions to snakebite, Lancet, 2, 1306, 10.1016/S0140-6736(85)91589-2 · DOI
- Wadee, 1987, Development of specific IgE antibodies after repeated exposure to snake venom, J Allergy Clin Immunol, 80, 695, 10.1016/0091-6749(87)90289-2 · DOI · Paper page
- deShazo, 1990, Reactions to the stings of the imported fire ant, N Engl J Med, 323, 462, 10.1056/NEJM199008163230707 · DOI
- Leynadier, 1997, Allergic reactions to North African scorpion venom evaluated by skin test and specific IgE, J Allergy Clin Immunol, 99, 851, 10.1016/S0091-6749(97)80022-X · DOI
- Portier, 1902, De l'action anaphylactique de certains venims, C R Soc Biol, 54, 170
- Togias, 1985, Anaphylaxis after contact with a jellyfish, J Allergy Clin Immunol, 75, 672, 10.1016/0091-6749(85)90092-2 · DOI
- Beyer, 2012, Anaphylaxis in an emergency setting—elicitors, therapy and incidence of severe allergic reactions, Allergy, 67, 1451, 10.1111/all.12012 · DOI
- Lee, 2011, Anaphylaxis: mechanisms and management, Clin Exp Allergy, 41, 923, 10.1111/j.1365-2222.2011.03779.x · DOI
- Palm, 2013, Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity, Immunity, 39, 976, 10.1016/j.immuni.2013.10.006 · DOI · Paper page
- Lilla, 2011, Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice, Blood, 118, 6930, 10.1182/blood-2011-03-343962 · DOI · Paper page
- Piliponsky, 2010, Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice, Am J Pathol, 176, 926, 10.2353/ajpath.2010.090342 · DOI
- Duttlinger, 1993, W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis, Development, 118, 705, 10.1242/dev.118.3.705 · DOI
- Reber, 2012, New models for analyzing mast cell functions in vivo, Trends Immunol, 33, 613, 10.1016/j.it.2012.09.008 · DOI · Paper page
- Prouvost-Danon, 1977, Effect of heating at 56 degrees C on mouse IgE antibodies, Immunochemistry, 14, 81, 10.1016/0019-2791(77)90284-1 · DOI · Paper page
- Strait, 2006, IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking, J Clin Invest, 116, 833, 10.1172/JCI25575 · DOI · Paper page
- Rivera, 2008, New insights on mast cell activation via the high affinity receptor for IgE, Adv Immunol, 98, 85, 10.1016/S0065-2776(08)00403-3 · DOI · Paper page
- Habermann, 1972, Biochemistry and pharmacology of the cortoxin complex. II. Possible interrelationships between toxicity and organ distribution of phospholipase A, crotapotin and their combination, Naunyn Schmiedebergs Arch Pharmacol, 273, 313, 10.1007/BF00499666 · DOI
- Liu, 1980, Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization, J Immunol, 124, 2728, 10.4049/jimmunol.124.6.2728 · DOI
- Wershil, 1991, Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha, J Clin Invest, 87, 446, 10.1172/JCI115016 · DOI
- Schafer, 2013, Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice, J Allergy Clin Immunol, 131, 541, 10.1016/j.jaci.2012.05.009 · DOI
- Bruhns, 2012, Properties of mouse and human IgG receptors and their contribution to disease models, Blood, 119, 5640, 10.1182/blood-2012-01-380121 · DOI · Paper page
- Artis, 2012, Forum: immunology: allergy challenged, Nature, 484, 458, 10.1038/484458a · DOI
- Risch, 2009, Snake venomics of the Siamese Russell's viper (Daboia russelli siamensis)—relation to pharmacological activities, J Proteomics, 72, 256, 10.1016/j.jprot.2009.01.006 · DOI · Paper page
- Ishizaka, 1966, Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity, J Immunol, 97, 75, 10.4049/jimmunol.97.1.75 · DOI
- Johansson, 1967, Immunological studies of an atypical (myeloma) immunoglobulin, Immunology, 13, 381
- Stanworth, 1993, The discovery of IgE, Allergy, 48, 67, 10.1111/j.1398-9995.1993.tb00687.x · DOI
- Stanworth, 1967, Specific inhibition of the Prausnitz-Kustner reaction by an atypical human myeloma protein, Lancet, 2, 330, 10.1016/S0140-6736(67)90171-7 · DOI
- Bilo, 2008, Epidemiology of insect-venom anaphylaxis, Curr Opin Allergy Clin Immunol, 8, 330, 10.1097/ACI.0b013e32830638c5 · DOI
- Russo, 1983, The relationship of the possible allergic response to jellyfish envenomation and serum antibody titers, Toxicon, 21, 475, 10.1016/0041-0101(83)90125-3 · DOI
- Haftenberger, 2013, [Prevalence of sensitisation to aeraoallergens and food allergens: results of the German Health Interview and Examination Survey for Adults (DEGS1)], Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 56, 687, 10.1007/s00103-012-1658-1 · DOI
- Langen, 2013, [Prevalence of allergic diseases in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)], Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 56, 698, 10.1007/s00103-012-1652-7 · DOI
- Sturm, 2007, Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy, Allergy, 62, 884, 10.1111/j.1398-9995.2007.01413.x · DOI
- Bousquet, 2006, Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project, Allergy, 61, 671, 10.1111/j.1398-9995.2006.01048.x · DOI
- Golden, 1989, Epidemiology of insect venom sensitivity, JAMA, 262, 240, 10.1001/jama.1989.03430020082033 · DOI
- Nicolaou, 2010, Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics, J Allergy Clin Immunol, 125, 191, 10.1016/j.jaci.2009.10.008 · DOI
- Schafer, 1996, IgE antibodies to Hymenoptera venoms in the serum are common in the general population and are related to indications of atopy, Allergy, 51, 372, 10.1111/j.1398-9995.1996.tb00144.x · DOI
- Sturm, 2014, Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare, J Allergy Clin Immunol, 133, 1635, 10.1016/j.jaci.2013.10.046 · DOI
- Hamilton, 2014, Allergic sensitization is a key risk factor for but not synonymous with allergic disease, J Allergy Clin Immunol, 134, 360, 10.1016/j.jaci.2014.02.022 · DOI
- Blumenthal, 2012, Genetic, epigenetic, and environmental factors in asthma and allergy, Ann Allergy Asthma Immunol, 108, 69, 10.1016/j.anai.2011.12.003 · DOI
- Holgate, 1999, Genetic and environmental interaction in allergy and asthma, J Allergy Clin Immunol, 104, 1139, 10.1016/S0091-6749(99)70005-9 · DOI
- Holloway, 2010, Genetics of allergic disease, J Allergy Clin Immunol, 125, S81, 10.1016/j.jaci.2009.10.071 · DOI
- McGowan, 2015, Influence of early-life exposures on food sensitization and food allergy in an inner-city birth cohort, J Allergy Clin Immunol, 135, 171, 10.1016/j.jaci.2014.06.033 · DOI
- Arumugam, 2011, Increased susceptibility of 129SvEvBrd mice to IgE-Mast cell mediated anaphylaxis, BMC Immunol, 12, 14, 10.1186/1471-2172-12-14 · DOI
- Brandt, 2003, Mast cells are required for experimental oral allergen-induced diarrhea, J Clin Invest, 112, 1666, 10.1172/JCI19785 · DOI
- Hart, 1998, Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice, J Exp Med, 187, 2045, 10.1084/jem.187.12.2045 · DOI · Paper page
- Vaz, 1977, Sensitivity to intravenous injections of histamine and serotonin in inbred mouse strains, Int Arch Allergy Appl Immunol, 53, 545, 10.1159/000231796 · DOI
- Muller, 2005, Bee venom allergy in beekeepers and their family members, Curr Opin Allergy Clin Immunol, 5, 343, 10.1097/01.all.0000173783.42906.95 · DOI · Paper page
- Meiler, 2008, In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure, J Exp Med, 205, 2887, 10.1084/jem.20080193 · DOI · Paper page
- Ozdemir, 2011, Mechanisms of immunotherapy to wasp and bee venom, Clin Exp Allergy, 41, 1226, 10.1111/j.1365-2222.2011.03812.x · DOI · Paper page
- Oettgen, 1994, Active anaphylaxis in IgE-deficient mice, Nature, 370, 367, 10.1038/370367a0 · DOI · Paper page
- Lilla, 2011, Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice, Blood, 118, 6930, 10.1182/blood-2011-03-343962 · DOI · Paper page
- Duttlinger, 1993, W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis, Development, 118, 705, 10.1242/dev.118.3.705 · DOI
- Sullivan, 2011, Genetic analysis of basophil function in vivo, Nat Immunol, 12, 527, 10.1038/ni.2036 · DOI · Paper page
- Liu, 1980, Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization, J Immunol, 124, 2728, 10.4049/jimmunol.124.6.2728 · DOI
- Marichal, 2013, A beneficial role for immunoglobulin E in host defense against honeybee venom, Immunity, 39, 963, 10.1016/j.immuni.2013.10.005 · DOI · Paper page
- Prouvost-Danon, 1977, Effect of heating at 56 degrees C on mouse IgE antibodies, Immunochemistry, 14, 81, 10.1016/0019-2791(77)90284-1 · DOI · Paper page
- Strait, 2006, IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking, J Clin Invest, 116, 833, 10.1172/JCI25575 · DOI · Paper page
- Ishizaka, 1986, Biological properties of a recombinant human immunoglobulin ε-chain fragment, Proc Natl Acad Sci U S A, 83, 8323, 10.1073/pnas.83.21.8323 · DOI
- Wakayama, 1998, IgG-mediated anaphylaxis via Fcγ receptor in CD40-deficient mice, Clin Exp Immunol, 114, 154, 10.1046/j.1365-2249.1998.00717.x · DOI
- Amiri, 1994, Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon γ knockout mice, J Exp Med, 180, 43, 10.1084/jem.180.1.43 · DOI · Paper page
- Haak-Frendscho, 1998, Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice, Immunology, 94, 115, 10.1046/j.1365-2567.1998.00478.x · DOI · Paper page
- Metz, 2006, Mast cells can enhance resistance to snake and honeybee venoms, Science, 313, 526, 10.1126/science.1128877 · DOI · Paper page
- Strait, 2002, Pathways of anaphylaxis in the mouse, J Allergy Clin Immunol, 109, 658, 10.1067/mai.2002.123302 · DOI
- Jonsson, 2011, Mouse and human neutrophils induce anaphylaxis, J Clin Invest, 121, 1484, 10.1172/JCI45232 · DOI
- Khodoun, 2013, Rapid desensitization of mice with anti-FcgammaRIIb/FcgammaRIII mAb safely prevents IgG-mediated anaphylaxis, J Allergy Clin Immunol, 132, 1375, 10.1016/j.jaci.2013.09.008 · DOI
Cited by
Sorted by citations
Mast cells and IgE in defense against venoms: Possible “good side” of allergy?
Galli, S. J., Starkl, P., Marichal, T., & Tsai, M. (2016) · Allergology International · doi:10.1016/j.alit.2015.09.002 · Cited by 73
Self-citationMast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy
Galli, S. J., Metz, M., Starkl, P., Marichal, T., & Tsai, M. (2020) · Allergo Journal International · doi:10.1007/s40629-020-00118-6 · Cited by 57
Self-citation
Metadata
- Authors
- Starkl, P., Marichal, T., Gaudenzio, N., Reber, L. L., Sibilano, R., Tsai, M., & Galli, S. J.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 137
- Issue
- 1
- Pages
- 246-257.e11
- ISSN
- 0091-6749
- PMC
- PMC4715494
- Cited by
- 65
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
